Overview

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

Status:
Completed
Trial end date:
2005-07-25
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Finasteride